AdvaMed Wary Of Japan's Ability To Improve Incremental Product Review
This article was originally published in PharmAsia News
Executive Summary
Japan is in need of device industry investment, but without the incentive of data exclusivity, the government needs to counter existing disincentives, says AdvaMed CEO.